Vertical Pharmaceuticals LLC, an Osmotica company, Announces Presentation of Phase III RVL-1201 Clinical Trial Data in Patients with Acquired Blepharoptosis (droopy eyelid)

September 18, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search